ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System , a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1] [2] [3] [4]
Codes for veterinary use (ATCvet codes ) can be created by placing the letter Q in front of the human ATC code: for example, QL .[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
L Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L02 Endocrine therapy
L03 Immunostimulants
L04 Immunosuppressants
References [ ]
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
gastrointestinal tract / metabolism (A )
stomach acid
Antacids
H2 antagonists
Proton-pump inhibitors
Antiemetics
Laxatives
Antidiarrhoeals / Antipropulsives
Anti-obesity drugs
Diabetes medication
Vitamins
Dietary minerals
blood and blood forming organs (B )
Antithrombotics
Antiplatelets
Anticoagulants
Thrombolytics / fibrinolytics
Antihemorrhagics
cardiovascular system (C )
cardiac therapy / antianginals
Cardiac glycosides
Antiarrhythmics
Cardiac stimulants
Antihypertensives
Diuretics
Vasodilators
Beta blockers
Calcium channel blockers
renin–angiotensin system
ACE inhibitors
Angiotensin II receptor antagonists
Renin inhibitors
Antihyperlipidemics
Statins
Fibrates
Bile acid sequestrants
skin (D )
Emollients
Cicatrizants
Antipruritics
Antipsoriatics
Medicated dressings
genitourinary system (G )endocrine system (H )infections andinfestations (J , P , QI )malignant disease (L01–L02 )immune disease (L03–L04 )
Immunomodulators
Immunostimulants
Immunosuppressants
muscles , bones , and joints (M )
Anabolic steroids
Anti-inflammatories
Non-steroidal anti-inflammatory drugs
Antirheumatics
Corticosteroids
Muscle relaxants
Bisphosphonates
brain andnervous system (N )
Analgesics
Anesthetics
Anorectics
Anti-ADHD agents
Antiaddictives
Anticonvulsants
Antidementia agents
Antidepressants
Antimigraine agents
Antiparkinson agents
Antipsychotics
Anxiolytics
Aphrodisiacs
Depressants
Entactogens
Entheogens
Euphoriants
Hallucinogens
Psychedelics
Dissociatives
Deliriants
Hypnotics / Sedatives
Mood stabilizers
Neuroprotectives
Nootropics
Neurotoxins
Orexigenics
Serenics
Stimulants
Wakefulness-promoting agents
respiratory system (R )sensory organs (S )
Ophthalmologicals
Otologicals
other ATC (V )
Antidotes
Contrast media
Radiopharmaceuticals
Dressings
Senotherapeutics
Drugs
Pharmacological classification systems
ATC codes
Medicine portal
Intracellular chemotherapeutic agents / antineoplastic agents (L01 )
SPs /MIs (M phase )
Block microtubule assembly
Vinca alkaloids (Vinblastine #
Vincristine #
Vindesine
Vinflunine §
Vinorelbine # )
Block microtubule disassembly
Taxanes (Cabazitaxel
Docetaxel #
Larotaxel
Ortataxel †
Paclitaxel #
Tesetaxel )
Epothilones (Ixabepilone )
DNA replication inhibitor
DNA precursors/antimetabolites (S phase )
Folic acid Purine Pyrimidine
DNA polymerase inhibitor (Cytarabine # )
Ribonucleotide reductase inhibitor (Gemcitabine # )
Deoxyribonucleotide
Ribonucleotide reductase inhibitor (Hydroxycarbamide # )
Topoisomerase inhibitors (S phase )
Crosslinking of DNA (CCNS )
Alkylating Platinum-based
Carboplatin #
Cisplatin #
Dicycloplatin
Nedaplatin
Oxaliplatin #
Satraplatin
Nonclassical Intercalation
Photosensitizers /PDT Other
Enzyme inhibitors Receptor antagonists
ERA (Atrasentan )
Retinoid X receptor (Bexarotene )
Sex steroid (Testolactone )
Other/ungrouped
# WHO-EM
‡ Withdrawn from market
Clinical trials :
† Phase III
§ Never to phase III
Targeted cancer therapy / antineoplastic agents (L01 )
CI monoclonal antibodies ("-mab")
Receptor tyrosine kinase
ErbB : HER1/EGFR (Cetuximab
Panitumumab )
HER2/neu (Pertuzumab , Trastuzumab (+hyaluronidase )
Trastuzumab emtansine
Trastuzumab deruxtecan )
Others for solid tumors Leukemia /lymphoma
lymphoid : CD20 (Ibritumomab
Obinutuzumab
Ofatumumab
Rituximab
Tositumomab ), CD30 (Brentuximab ), CD52 (Alemtuzumab )
myeloid : CD33 (Gemtuzumab ozogamicin )
Other
Amivantamab
Atezolizumab
Avelumab
Belantamab mafodotin
Bermekimab
Blinatumomab
Cemiplimab
Daratumumab
Dinutuximab beta
Dostarlimab
Durvalumab
Elotuzumab
Enfortumab vedotin
Inotuzumab ozogamicin
Ipilimumab
Isatuximab
Mogamulizumab
Moxetumomab pasudotox
Necitumumab
Nivolumab
Olaratumab
Pembrolizumab
Polatuzumab vedotin
Ramucirumab
Tafasitamab
Tyrosine kinase inhibitors ("-nib")
Receptor tyrosine kinase
ErbB : HER1/EGFR (Afatinib
Brigatinib
Dacomitinib
Erlotinib
Gefitinib
Icotinib
Mobocertinib
Olmutinib
Osimertinib
Rociletinib
Vandetanib )
HER1/EGFR and HER2/neu
Lapatinib
Neratinib
Tucatinib
ALK
Alectinib
Brigatinib
Ceritinib
RET inhibitors: Entrectinib (ALK, ROS1, NTRK), Larotrectinib (NTRK), Infigratinib , Pemigatinib (FGFR), Pralsetinib , Selpercatinib (VEGFR, FGFR), Vandetanib (VEGFR, EGFR).
Non-receptor
Janus kinase
Baricitinib
Fedratinib
Filgotinib
Lestaurtinib
Momelotinib
Pacritinib
Ruxolitinib
Bruton's
Acalabrutinib
Ibrutinib
Zanubrutinib
Other
Immunostimulants (L03 )
Endogenous
Cytokines
Colony-stimulating factors Interferons
alpha :
beta :
Interferon beta natural
Interferon beta 1a
Interferon beta 1b
Interferon gamma
Interleukins
Other protein / peptide
Growth hormone
Immunocyanin
Pegademase
Prolactin
Tasonermin
Other
Female sex steroids
Histamine dihydrochloride
Poly ICLC
Vitamin D
Exogenous
beta-glucan
heterocyclic compound
hydroxyquinoline
Mifamurtide
oligopeptides
polyribonucleotide
thiazolidine
vaccines
Immunosuppressive drugs / Immunosuppressants (L04 )
Intracellular (initiation)
Antimetabolites
purine synthesis inhibitors
Azathioprine
Mycophenolic acid
pyrimidine synthesis inhibitors
Macrolides / other IL-2 inhibitors
FKBP /Cyclophilin /Calcineurin
Ciclosporin
Pimecrolimus
Tacrolimus
Voclosporin
IMiDs
Lenalidomide
Pomalidomide
Thalidomide
PDE4 inhibitor
Intracellular (reception)
Extracellular
Antibodies
Monoclonal
Serum target (noncellular)
Complement component 5
TNF
Interleukin 5
Immunoglobulin E
Cellular target
CD3
CD4
CD11a
CD18
CD20
CD23
CD40
CD62L/L-selectin
CD80
CD147/Basigin
CD154
Unsorted
Polyclonal
Anti-thymocyte globulin
Anti-lymphocyte globulin
-cept (Fusion )
CTLA-4
TNF inhibitor
Aflibercept
Alefacept
Rilonacept
Unsorted
Baricitinib
Blisibimod
Filgotinib
Tofacitinib
Upadacitinib